ArticleAsian Pacific journal of cancer prevention : APJCP2021

The Impact of Sorafenib in Combination with Transarterial Chemoembolization on the Outcomes of Intermediate-Stage Hepatocellular Carcinoma.

Masaki Kaibori et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.